Largest pharmaceuticals by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Definium Therapeutics has the lowest figure of the 35 pharmaceuticals ranked by total debt, at PLN 163.2M, followed by Rhythm Pharmaceuticals (PLN 435M) and Axsome Therapeutics (PLN 754.8M). Figures as of 18 Nov 2026, 15:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 35
- Lowest
- Definium TherapeuticsPLN 163.2M
- Median
- PLN 21.2B
- Combined market value
- PLN 20.55T
- Countries
- 10
- Not ranked
- 26no total debt on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total debt ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Definium TherapeuticsDFTX · Health Care | PLN 163.2M | PLN 16.2B | PLN 118.29 | 0.14% up | 169% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 435M | PLN 32.8B | PLN 472.50 | 0.78% up | 13% up | ||
| 3 | Axsome TherapeuticsAXSM · Health Care | PLN 754.8M | PLN 28.4B | PLN 540.47 | 1.12% down | 7% down | ||
| 4 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 778.9M | PLN 50.3B | PLN 60.29 | 1.39% up | 5% up | ||
| 5 | Cogent BiosciencesCOGT · Health Care | PLN 896.2M | PLN 20B | PLN 115.05 | 2.75% up | 20% down | ||
| 6 | TG TherapeuticsTGTX · Health Care | PLN 987.6M | PLN 38.6B | PLN 255.31 | 1.26% up | 107% up | ||
| 7 | CytokineticsCYTK · Health Care | PLN 1.2B | PLN 29.2B | PLN 209.47 | 0.87% up | 20% down | ||
| 8 | Legend BiotechLEGN · Health Care | PLN 1.3B | PLN 12.7B | PLN 65.66 | 1.37% up | 42% down | ||
| 9 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 1.4B | PLN 39B | PLN 1,680.85 | 0.93% down | 24% down | ||
| 10 | InsmedINSM · Health Care | PLN 2.2B | PLN 106.8B | PLN 486.97 | 0.61% down | 40% down | ||
| 11 | Ascendis PharmaASND · Health Care | PLN 3.2B | PLN 71.2B | PLN 1,085.56 | 0.44% down | 28% up | ||
| 12 | BeOne MedicinesONC · Health Care | PLN 4.1B | PLN 186B | PLN 1,628.38 | 2.00% down | 17% up | ||
| 13 | Ionis PharmaceuticalsIONS · Health Care | PLN 7.3B | PLN 18.1B | PLN 108.66 | 0.24% up | 64% down | ||
| 14 | Regeneron PharmaceuticalsREGN · Health Care | PLN 8B | PLN 399.8B | PLN 3,864.71 | 0.36% up | 36% up | ||
| 15 | BridgeBio PharmaBBIO · Health Care | PLN 8.1B | PLN 60.7B | PLN 311.64 | 0.92% up | 17% up | ||
| 16 | Amneal PharmaceuticalsAMRX · Health Care | PLN 10.3B | PLN 30.1B | PLN 86.44 | 1.80% up | 83% up | ||
| 17 | Elanco Animal HealthELAN · Health Care | PLN 16.2B | PLN 52.9B | PLN 105.74 | 1.74% up | 20% up | ||
| 18 | GenmabGMAB · Health Care | PLN 21.2B | PLN 128.4B | PLN 208.27 | 0.31% down | 70% up | ||
| 19 | Jazz PharmaceuticalsJAZZ · Health Care | PLN 21.5B | PLN 62.7B | PLN 977.41 | 0.99% up | 37% up | ||
| 20 | Royalty PharmaRPRX · Health Care | PLN 36B | PLN 158.8B | PLN 276.25 | 0.04% up | 78% up | ||
| 21 | ZoetisZTS · Health Care | PLN 36.4B | PLN 136.3B | PLN 335.40 | 0.07% down | 29% down | ||
| 22 | Abbott LaboratoriesABT · Health Care | PLN 52B | PLN 728.7B | PLN 420.71 | 0.07% down | 17% down | ||
| 23 | ViatrisVTRS · Health Care | PLN 57.9B | PLN 95B | PLN 82.84 | 0.76% up | 96% up | ||
| 24 | GSKGSK · Health Care | PLN 77.1B | PLN 395.5B | PLN 197.33 | 0.32% down | 6% up | ||
| 25 | Novo NordiskNVO · Health Care | PLN 78.1B | PLN 709.4B | PLN 160.96 | 1.63% down | 17% down | ||
| 26 | SanofiSNY · Health Care | PLN 83.4B | PLN 458B | PLN 190.72 | 0.20% down | 4% down | ||
| 27 | NovartisNVS · Health Care | PLN 115.5B | PLN 1.19T | PLN 630.65 | 1.43% down | 25% up | ||
| 28 | AstraZenecaAZN · Health Care | PLN 119.1B | PLN 1.12T | PLN 722.30 | 1.44% down | 2% up | ||
| 29 | Takeda PharmaceuticalTAK · Health Care | PLN 122.9B | PLN 275.5B | PLN 86.24 | 0.88% down | 54% up | ||
| 30 | Eli LillyLLY · Health Care | PLN 170.9B | PLN 5.02T | PLN 5,630.96 | 1.06% down | 35% up | ||
| 31 | Bristol-Myers SquibbBMY · Health Care | PLN 181.4B | PLN 495B | PLN 242.14 | 1.83% down | 34% up | ||
| 32 | Johnson & JohnsonJNJ · Health Care | PLN 192.7B | PLN 2.67T | PLN 1,110.41 | 0.90% down | 38% up | ||
| 33 | Merck & CoMRK · Health Care | PLN 198.2B | PLN 1.39T | PLN 565.56 | 1.89% down | 51% up | ||
| 34 | PfizerPFE · Health Care | PLN 260.5B | PLN 647.9B | PLN 113.68 | 0.69% down | 14% up | ||
| 35 | AbbVieABBV · Health Care | PLN 271.4B | PLN 2.06T | PLN 1,163.04 | 1.21% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0206 PLN). 26 companies have no total debt on file and are not ranked here.
Questions and answers
Which pharmaceuticals have the lowest total debt?
Definium Therapeutics (PLN 163.2M), Rhythm Pharmaceuticals (PLN 435M) and Axsome Therapeutics (PLN 754.8M) have the lowest total debt of the 35 pharmaceuticals ranked here as of 18 Nov 2026, 15:16 UTC.
How many pharmaceuticals are in this ranking?
35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 35 pharmaceuticals ranked by total debt have a combined market value of PLN 20.55T as of 18 Nov 2026, 15:16 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.